Does Teladoc's Acquisition Strategy Boost Growth and Global Footprint?

21.11.25 17:06 Uhr

Werte in diesem Artikel
Aktien

156,55 EUR 1,55 EUR 1,00%

Indizes

25.236,9 PKT 218,6 PKT 0,87%

23.214,7 PKT 189,1 PKT 0,82%

Teladoc Health TDOC has been banking on acquisitions to boost growth, which has expanded its distribution capabilities, broadened its service offerings and created a global footprint. Its acquisition strategy is centered on acquiring products, capabilities, clinical specialties, technologies and distribution channels that are highly scalable and rapidly growing. Some of its notable acquisitions are Healthiest You, BetterHelp, Consult-a-Doctor, and AmeriDoc. Its acquisition of InTouch Health and strategic investment in Vida Health, a personalized virtual care platform for physical and behavioral health, positioned Teladoc as a leading provider of virtual care for health systems.In 2025, Teladoc acquired Catapult Health (now included in the Integrated Care segment), while Uplift’s buyout strengthened its leadership position in virtual mental health. The acquisitions of Best Doctors Advance Medical and MédecinDirect in recent years expanded the company’s international operations. This August, Teladoc acquired Australian virtual care provider Telecare to expand its international presence and specialist services in the Asia-Pacific region.The acquisitions of Catapult Health, Uplift, and Telecare added 100 basis points to TDOC’s top line for the first nine months of 2025, while the acquisition of Catapult Health and Telecare increased Integrated Care’s total revenues by 200 basis points over the same time frame.Given that the company continues to evaluate and pursue acquisition opportunities that are complementary to its business and virtual healthcare strategy, more such activities are expected on this front going forward.What About TDOC’s Peers?HCA Healthcare HCA has been emphasizing acquisitions to add scale to its business. HCA Healthcare’s inorganic growth strategies have led to an increase in patient volumes, network expansion across several markets and added more hospitals to its portfolio. All these buyouts help HCA Healthcare boost its portfolio and penetrate further into different geographies.Strategic acquisitions position Elevance Health ELV for long-term growth. Some of Elevance’s major purchases include the Missouri and Nebraska Medicaid plans of WellCare Health, Beacon Health buyout, BioPlus in Carelon and others. All these strategic acquisitions bode well for Elevance. It prioritizes aligning investments to optimize its core operations.TDOC’s Price PerformanceShares of Teladoc have lost 25.2% year to date against the industry’s growth of 4.2%.Image Source: Zacks Investment ResearchTDOC’s Expensive ValuationTDOC is trading at a forward 12-month price-to-sales multiple of 0.47, higher than the industry average of 0.46.Image Source: Zacks Investment ResearchEstimates Movement for TDOCThe Zacks Consensus Estimate for TDOC’s fourth-quarter 2025 and first-quarter 2026 witnessed no movement in the past 30 days. While the consensus estimate for full-year 2025 loss improved by 2 cents, the one for 2026 loss has narrowed by 1 cent in the same time frame.Image Source: Zacks Investment ResearchThe consensus estimate for TDOC’s 2025 revenues indicates a year-over-year decline, but the same for 2026 suggests a year-over-year increase. The consensus estimate for 2025 and 2026 EPS indicates year-over-year increases.TDOC stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HCA Healthcare, Inc. (HCA): Free Stock Analysis Report Teladoc Health, Inc. (TDOC): Free Stock Analysis Report Elevance Health, Inc. (ELV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Strategy (ex MicroStrategy) und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Strategy (ex MicroStrategy)

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Strategy (ex MicroStrategy)

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Strategy (ex MicroStrategy)

Wer­bung

Analysen zu Strategy (ex MicroStrategy)

DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
28.07.2017Microstrategy A HoldDeutsche Bank AG
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
11.12.2015Microstrateg a BuyMizuho
DatumRatingAnalyst
28.07.2017Microstrategy A HoldDeutsche Bank AG
19.10.2015Microstrateg a HoldLake Street
31.10.2012Microstrateg a neutralROTH Capital Partners, LLC
30.10.2012Microstrateg a neutralUBS AG
31.07.2012Microstrateg a neutralUBS AG
DatumRatingAnalyst
16.03.2005Update Microstrategy Inc.: SellWedbush Morgan
09.02.2005Update Microstrategy Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Strategy (ex MicroStrategy) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen